SPY303.53+4.45 1.49%
DIA255.77+5.52 2.21%
IXIC9,412.36+72.14 0.77%

JP Morgan Maintains Overweight on Radius Health, Lowers Price Target to $27

JP Morgan maintains Radius Health (NASDAQ:RDUS) with a Overweight and lowers the price target from $32 to $27.

Benzinga · 05/12/2020 15:09

JP Morgan maintains Radius Health (NASDAQ:RDUS) with a Overweight and lowers the price target from $32 to $27.